51 reports

  • Bladder cancer
  • Economic burden of bladder cancer
  • Bladder Cancer
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Pfizer Inc.

Key Features of the Report: - Bladder Cancer Patient Flow - Bladder Cancer Prevalence - Bladder Cancer Diagnosed Patients - Bladder Cancer Treated Patients

  • Bladder Cancer
  • Europe
  • France
  • World
  • Forecast
  • BLADDER CANCER STAGING SYSTEM
  • BLADDER CANCER RISK FACTORS
  • Bladder Cancer
  • Japan
  • Demand
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.

Bladder Cancer Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Bladder Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Bladder Cancer pipeline products,

  • Bladder Cancer
  • France
  • Germany
  • Italy
  • Market Size
  • Bladder Cancer Risk Factors
  • lists two of the major risks factors for bladder cancer.
  • Bladder Cancer
  • Cancer
  • Japan
  • United Kingdom
  • Forecast

Bladder Cancer 2017

7595 8355 6456

Bladder Cancer 2017 ##.

  • Bladder Cancer
  • Therapy
  • United States
  • Forecast

Key Features of the Report: - Bladder Cancer Patient Flow - Bladder Cancer Prevalence - Bladder Cancer Diagnosed Patients - Bladder Cancer Treated Patients

  • Bladder Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • Bladder Cancer Overview
  • Thiotepa
  • Bladder Cancer
  • Therapy
  • China
  • Trade
  • Lilly Pharmaceutical China Inc
  • Bladder Cancer Overview
  • IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION
  • Bladder Cancer
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.

Bladder Cancer Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Bladder Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Bladder Cancer pipeline products,

  • Bladder Cancer
  • Europe
  • France
  • Germany
  • Market Size

Japan Bladder Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bladder Cancer Treatments ##) Bladder Cancer Pipeline ##) Japan Bladder Cancer Epidemiology ##) Marke

  • Bladder Cancer
  • Cancer
  • Pathology
  • Japan
  • Market Size

Italy Bladder Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bladder Cancer Treatments ##) Bladder Cancer Pipeline ##) Italy Bladder Cancer Epidemiology ##) Marke

  • Bladder Cancer
  • Cancer
  • Pathology
  • Italy
  • Market Size

Germany Bladder Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bladder Cancer Treatments ##) Bladder Cancer Pipeline ##) Germany Bladder Cancer Epidemiology ##) M

  • Bladder Cancer
  • Cancer
  • Pathology
  • Germany
  • Market Size

France Bladder Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bladder Cancer Treatments ##) Bladder Cancer Pipeline ##) France Bladder Cancer Epidemiology ##) Mar

  • Bladder Cancer
  • Cancer
  • Pathology
  • France
  • Market Size

UK Bladder Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bladder Cancer Treatments ##) Bladder Cancer Pipeline ##) UK Bladder Cancer Epidemiology ##) Marketed Dr

  • Bladder Cancer
  • Cancer
  • Pathology
  • United Kingdom
  • Market Size

US Bladder Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bladder Cancer Treatments ##) Bladder Cancer Pipeline ##) US Bladder Cancer Epidemiology ##) Marketed Dr

  • Bladder Cancer
  • Cancer
  • Pathology
  • Market Size

Spain Bladder Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bladder Cancer Treatments ##) Bladder Cancer Pipeline ##) Spain Bladder Cancer Epidemiology ##) Marke

  • Bladder Cancer
  • Cancer
  • Pathology
  • Spain
  • Market Size
  • BLADDER CANCER
  • Unaccomplished Trials of Bladder Cancer
  • Bladder Cancer
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.

Welcome to having the world of bladder cancer at your fingertips with " Target Atlas in Bladder Cancer: A Competitive Outlook"!

  • Bladder Cancer
  • Cancer
  • STAGES AND HISTOPATHOLOGY OF BLADDER CANCER
  • Major Histopathology in Bladder Cancer
  • Bladder Cancer
  • Cancer
  • Pathology
  • Europe
  • Bladder Cancer Treatment Drugs Sales Volume (Billion
  • Major Producer Facility Location
  • Bladder Cancer
  • China
  • Bristol-Myers Squibb China Inc Ltd
  • Sanofi-Synthelabo Inc.
  • Schering-Plough Corporation
  • LEADING TREATMENTS FOR BLADDER CANCER
  • BLADDER CANCER STAGING SYSTEMS
  • Bladder Cancer
  • United States
  • GlobalData's company
  • Roche Group
  • Spectrum Pharmaceuticals, Inc.
  • 5.2 BLADDER CANCER
  • Phase III Timeline in Bladder Cancer
  • Bladder Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

Incidence Rate of Bladder Cancer by Ethnicity (US) ## Bladder Cancer Mortality ## Table ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • Latest Clinical Trials News on Bladder Cancer
  • Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials
  • Bladder Cancer
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Merck & Co., Inc.
  • Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Overview
  • BIOLOGIC FOR SUPERFICIAL BLADDER CANCER - DRUG PROFILE
  • Bladder Cancer
  • Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • DRUGS TO INHIBIT TYRO-3 FOR BLADDER CANCER - DRUG PROFILE
  • SMALL MOLECULE TO INHIBIT TYRO3 FOR BLADDER CANCER - DRUG PROFILE
  • Bladder Cancer
  • Cancer
  • Therapy
  • United States
  • Product Initiative
  • Viralytics Enters into Partnership with University of Surrey
  • PARTNERSHIPS
  • Bladder Cancer
  • Lung Cancer
  • Pharmaceutical
  • United States
  • Viralytics Limited
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Bladder Cancer
  • Cancer
  • Chemotherapy
  • World
  • Product Initiative

Bladder cancer occurs in tissues of the urinary bladder.

  • Bladder Cancer
  • Cancer